4//SEC Filing
Cunningham, Richard Anthony 4
Accession 0001209191-23-052650
CIK 0001815974other
Filed
Oct 10, 8:00 PM ET
Accepted
Oct 11, 5:25 PM ET
Size
5.6 KB
Accession
0001209191-23-052650
Insider Transaction Report
Form 4
Cunningham, Richard Anthony
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2023-10-06+600,000→ 600,000 totalExercise: $3.03Exp: 2033-10-05→ Common Stock (600,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest and become exercisable as follows: ratably in 16 quarterly installments (37,500 per installment) on the first day of each calendar quarter commencing with January 1, 2024, such that option will be full vested on October 1, 2027.
Documents
Issuer
Anebulo Pharmaceuticals, Inc.
CIK 0001815974
Entity typeother
Related Parties
1- filerCIK 0001624783
Filing Metadata
- Form type
- 4
- Filed
- Oct 10, 8:00 PM ET
- Accepted
- Oct 11, 5:25 PM ET
- Size
- 5.6 KB